Back to results
US 2016/0106689 A1Published application
Use
AssigneeNovabiotics Limited
InventorDeborah O'NEIL
Life of this patent
Estimating the term…
Abstract
The present invention relates to compositions comprising cysteamine or a derivative thereof for use in treating infections caused by yeasts or moulds.
Claims22
-39. (canceled)
A method of treating a bacterial or fungal infection or disease or condition therewith associated in a patient comprising administering an effective amount of cystamine to the patient.
A method of preventing biofilm formation in an environment comprising the step of administering an effective amount of cysteamine to the environment.
Dependencies are inferred from the claim text.